Zoetis Inc. Class A Common Stock · Transaction Sep 18, 2026 · Filed Oct 12, 2026 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · ZTS
+1.22% · +$0.9600 · Vol Not reported
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Zoetis Inc
Pharmaceuticals
$79.38
Follow $ZTS
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ZTS by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredFri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET · ZTS
MethodologyZTS
Zoetis Inc
Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
56/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Oct 16 · last completed session · Markets closed · resumes Mon 9:30 ET
AI Analysis
SovereignWhy is ZTS moving today?
Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Zoetis Inc
PHARMACEUTICAL PREPARATIONSListed since
2013
Employees
15K
Country
US
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$78.29
Day high
$80.59
Day low
$78.29
Previous close
$78.42
52W high
$147.53
-46.19% from high
52W low
$69.10
13% of range
Market cap
$32.8B
P/E
12.55×
EPS
$6.08
Beta
-0.13
Shares out
413.2M
Avg volume
4.5M
VWAP
$78.42
Last session
Price history computed in-house
1W
+6.11%
1M
+11.18%
3M
+4.17%
1Y
-44.90%
YTD
-36.91%
SMA 50 $73.98 · above
SMA 200 $95.87 · below
52W position 13%
ZTS overview
Related filings and maps
Public disclosures
Congress activity in ZTS
27 filers · 44 buys · 42 sells (2 labeled S (partial)) · Oct 7, 2015 to Sep 18, 2026 · House 73 / Senate 13
All available history · Latest 5 of 86 lines · Read Oct 18, 2026, 11:58 AM UTC
Official filing ↗
Zoetis Inc. Class A Common Stock · Transaction Jul 17, 2026 · Filed Sep 4, 2026 · $1,001 to $15,000
Zoetis Inc. Class A Common Stock · Transaction Jun 16, 2026 · Filed Jul 2, 2026 · $1,001 to $15,000
Zoetis Inc. Class A Common Stock · Transaction Apr 14, 2026 · Filed May 8, 2026 · $1,001 to $15,000
Zoetis Inc. Class A Common Stock · Transaction Mar 13, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
Federal contracts
ZTS contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ZTS in this window.
Lobbying spend
ZTS lobbying filings, year to date.
Registered lobbying filings matched to Zoetis Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ZTS in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for ZTS.